Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefs
- PMID: 17287373
- PMCID: PMC2861362
- DOI: 10.1176/appi.ps.58.2.181
Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefs
Abstract
Objective: Individuals with direct care responsibilities in 348 drug abuse treatment units were surveyed to obtain a description of the workforce and to assess support for evidence-based therapies.
Methods: Surveys were distributed to 112 programs participating in the National Drug Abuse Treatment Clinical Trials Network (CTN). Descriptive analyses characterized the workforce. Analyses of covariance tested the effects of job category on opinions about evidence-based practices and controlled for the effects of education, modality (outpatient or residential), race, and gender.
Results: Women made up two-thirds of the CTN workforce. One-third of the workforce had a master's or doctoral degree. Responses from 1,757 counselors, 908 support staff, 522 managers-supervisors, and 511 medical staff (71% of eligible participants) suggested that the variables that most were most consistently associated with responses were job category (19 of 22 items) and education (20 of 22 items). Managers-supervisors were the most supportive of evidence-based therapies, and support staff were the least supportive. Generally, individuals with graduate degrees had more positive opinions about evidence-based therapies. Support for using medications and contingency management was modest across job categories.
Conclusions: The relatively traditional beliefs of support staff could inhibit the introduction of evidence-based practices. Programs initiating changes in therapeutic approaches may benefit from including all employees in change efforts.
Comment in
-
Don'T forget the workforce.Psychiatr Serv. 2007 Feb;58(2):191. doi: 10.1176/ps.2007.58.2.191. Psychiatr Serv. 2007. PMID: 17287374 No abstract available.
References
-
- National Drug Abuse Treatment Clinical Trials Network. Bethesda, Md: National Institute on Drug Abuse; Available at www.drugabuse.gov/CTN.
-
- Peirce JM, Petry NM, Stitzer MC, et al. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network Study. Archives of General Psychiatry. 2006;63:201–208. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U10-DA13710/DA/NIDA NIH HHS/United States
- U10 DA013046/DA/NIDA NIH HHS/United States
- U10-DA15815/DA/NIDA NIH HHS/United States
- U10-DA15831/DA/NIDA NIH HHS/United States
- U10-DA13038/DA/NIDA NIH HHS/United States
- U10-DA13720/DA/NIDA NIH HHS/United States
- U10-DA13732/DA/NIDA NIH HHS/United States
- U10 DA013714/DA/NIDA NIH HHS/United States
- U10-DA13716/DA/NIDA NIH HHS/United States
- U10 DA013711/DA/NIDA NIH HHS/United States
- U10 DA013710/DA/NIDA NIH HHS/United States
- U10 DA015815/DA/NIDA NIH HHS/United States
- U10 DA013720/DA/NIDA NIH HHS/United States
- U10-DA13711/DA/NIDA NIH HHS/United States
- U10 DA015831/DA/NIDA NIH HHS/United States
- U10 DA013035/DA/NIDA NIH HHS/United States
- U10-DA13043/DA/NIDA NIH HHS/United States
- U10-DA13036/DA/NIDA NIH HHS/United States
- U10-DA13046/DA/NIDA NIH HHS/United States
- U10 DA013036/DA/NIDA NIH HHS/United States
- U10-DA13035/DA/NIDA NIH HHS/United States
- U10 DA013732/DA/NIDA NIH HHS/United States
- U10-DA13045/DA/NIDA NIH HHS/United States
- U10 DA013043/DA/NIDA NIH HHS/United States
- U10-DA13034/DA/NIDA NIH HHS/United States
- U10-DA15833/DA/NIDA NIH HHS/United States
- U10-DA13714/DA/NIDA NIH HHS/United States
- U10 DA013716/DA/NIDA NIH HHS/United States
- U10 DA013045/DA/NIDA NIH HHS/United States
- U10 DA013034/DA/NIDA NIH HHS/United States
- U10 DA013727/DA/NIDA NIH HHS/United States
- U10 DA015833/DA/NIDA NIH HHS/United States
- U10 DA013038/DA/NIDA NIH HHS/United States
- U10-DA13727/DA/NIDA NIH HHS/United States